Genital HSV-1 is significantly less contagious than genital HSV-2, and its transmission risk drops substantially over time. Most genital HSV-1 is acquired through receiving oral sex from someone with oral herpes, not from genital-to-genital contact. If you or a partner has a genital HSV-1 infection, the actual risk of passing it on is lower than many people expect.
How Genital HSV-1 Spreads
The most common way someone gets genital HSV-1 is through oral sex with a partner who carries HSV-1 in or around their mouth. This is the primary route. Genital-to-genital transmission of HSV-1 is uncommon because the virus sheds from the genital area far less frequently than HSV-2 does, and far less frequently than HSV-1 sheds from the mouth.
This distinction matters. If your partner has genital HSV-1, the risk to you during vaginal or penetrative sex is considerably lower than if they had genital HSV-2. The virus simply reactivates less often in genital tissue than HSV-2 does, which means fewer opportunities for it to pass to someone else.
Viral Shedding Drops Quickly Over Time
The virus can be present on the skin even when no sores are visible, a process called asymptomatic shedding. This is the main concern for transmission outside of outbreaks. But research from the University of Washington tracked genital HSV-1 shedding over time and found a sharp decline.
At two months after the initial infection, participants shed HSV-1 on about 12% of days. By 11 months, that rate had fallen to 7% of days. Some participants shed no virus at all. Among those who were still shedding at 11 months, a follow-up at two years showed the rate had dropped further to just 1.3% of days. That means for many people with an established genital HSV-1 infection, the virus is present on the skin only a handful of days per year, if at all.
This declining pattern is unique to genital HSV-1. Genital HSV-2, by contrast, continues to shed frequently for years. The biological reason is straightforward: HSV-1 reactivates less efficiently from the nerve clusters near the base of the spine than it does from the nerve clusters near the face, where it evolved to thrive.
Outbreaks Are Infrequent
Genital HSV-1 typically causes fewer recurrences than HSV-2. Many people have one initial outbreak and then rarely or never have another. HSV-2 accounts for roughly 90% of symptomatic genital herpes episodes, according to WHO estimates, which gives you a sense of how much less active HSV-1 is in the genital area. Fewer outbreaks means fewer periods of high viral activity, and that translates directly to lower transmission risk.
Genital HSV-1 Is Still Common
Despite the lower per-encounter transmission risk, genital HSV-1 infections are widespread. An estimated 376 million people worldwide had genital HSV-1 as of 2020. The reason is simple: oral HSV-1 is extremely common, and oral sex is a normal part of most sexual relationships. So while a person with genital HSV-1 is unlikely to pass the infection genitally to a partner, the virus itself circulates easily through oral-to-genital contact from people who carry it in their mouths.
This is an important nuance. The bigger risk in most relationships isn’t a partner’s genital HSV-1 infection. It’s oral HSV-1, which sheds more frequently from the mouth and can be transmitted through kissing or oral sex regardless of whether either person has visible cold sores.
What Reduces the Risk Further
Avoiding sexual contact during outbreaks is the most straightforward precaution. The virus is most contagious when sores are present and in the days just before and after an outbreak, when tingling, itching, or burning sensations (called prodromal symptoms) signal that the virus is active at the skin’s surface.
Condoms provide a physical barrier, but the data on their effectiveness specifically for HSV-1 is limited. One study found no clear association between condom use and HSV-1 transmission rates, likely because the virus can shed from skin not covered by a condom and because most genital HSV-1 comes from oral contact anyway. That said, condoms still reduce skin-to-skin contact in the genital area and are worth using for broader STI prevention.
Daily antiviral medication is well-studied for reducing HSV-2 transmission, but the CDC notes that suppressive therapy to prevent genital HSV-1 transmission to sexual partners has not been studied. Antivirals can reduce outbreak frequency and severity for the person taking them, but there is no established data showing they lower the already-low genital shedding rate enough to make a measurable difference in partner transmission for HSV-1 specifically.
Putting the Risk in Perspective
If your partner has an established genital HSV-1 infection (meaning they’ve had it for more than a year), the virus is likely shedding on fewer than 7% of days, possibly closer to 1%. Not every day of shedding leads to transmission, either. The amount of virus present during asymptomatic shedding is often too low to establish a new infection.
Genital-to-genital HSV-1 transmission in long-term couples is rare enough that many sexual health clinicians consider it a low-risk scenario. The combination of infrequent shedding, declining viral activity over time, and fewer outbreaks makes genital HSV-1 one of the least transmissible forms of herpes in the genital setting. For context, HSV-2 sheds on roughly 15 to 20% of days even years after infection, making it several times more contagious genitally than HSV-1.
None of this means the risk is zero. Transmission can happen during asymptomatic shedding, and the first year after infection carries the highest shedding rates. But for most people living with genital HSV-1, the practical risk of passing it to a partner through genital contact is low and gets lower with time.